Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electronic Health Records | 60 | 2024 | 4811 | 5.110 |
Why?
|
Models, Statistical | 37 | 2022 | 5079 | 3.410 |
Why?
|
Algorithms | 57 | 2024 | 14031 | 3.130 |
Why?
|
Biometry | 18 | 2018 | 563 | 2.950 |
Why?
|
Natural Language Processing | 26 | 2022 | 1162 | 2.430 |
Why?
|
Proportional Hazards Models | 31 | 2022 | 12463 | 2.180 |
Why?
|
Data Interpretation, Statistical | 19 | 2019 | 2691 | 1.860 |
Why?
|
Computer Simulation | 42 | 2023 | 6240 | 1.760 |
Why?
|
Phenotype | 30 | 2023 | 16591 | 1.740 |
Why?
|
Aneurysm, Ruptured | 14 | 2021 | 464 | 1.580 |
Why?
|
Intracranial Aneurysm | 18 | 2024 | 1285 | 1.510 |
Why?
|
ROC Curve | 26 | 2024 | 3579 | 1.390 |
Why?
|
Arthritis, Rheumatoid | 20 | 2023 | 3763 | 1.310 |
Why?
|
International Classification of Diseases | 9 | 2020 | 909 | 1.310 |
Why?
|
Survival Analysis | 18 | 2023 | 10090 | 1.100 |
Why?
|
Risk Assessment | 26 | 2024 | 23995 | 1.090 |
Why?
|
Case-Control Studies | 29 | 2022 | 22176 | 1.020 |
Why?
|
Likelihood Functions | 8 | 2019 | 992 | 1.000 |
Why?
|
Genetic Association Studies | 8 | 2020 | 2735 | 1.000 |
Why?
|
Peptides, Cyclic | 3 | 2017 | 392 | 0.910 |
Why?
|
Information Storage and Retrieval | 4 | 2019 | 819 | 0.900 |
Why?
|
Regression Analysis | 8 | 2017 | 6343 | 0.890 |
Why?
|
Research Design | 8 | 2024 | 6180 | 0.850 |
Why?
|
Sigmoid Neoplasms | 1 | 2022 | 54 | 0.800 |
Why?
|
Sample Size | 10 | 2020 | 841 | 0.800 |
Why?
|
Autoantibodies | 7 | 2018 | 2116 | 0.770 |
Why?
|
Probability | 7 | 2022 | 2477 | 0.760 |
Why?
|
Data Mining | 5 | 2021 | 551 | 0.730 |
Why?
|
Semantics | 2 | 2022 | 601 | 0.730 |
Why?
|
Inflammatory Bowel Diseases | 14 | 2022 | 2422 | 0.710 |
Why?
|
Humans | 232 | 2024 | 761504 | 0.700 |
Why?
|
Medical Record Linkage | 1 | 2021 | 285 | 0.700 |
Why?
|
Prognosis | 27 | 2022 | 29625 | 0.660 |
Why?
|
Validation Studies as Topic | 1 | 2019 | 162 | 0.630 |
Why?
|
Polymorphism, Single Nucleotide | 15 | 2019 | 15936 | 0.620 |
Why?
|
Lipoproteins, LDL | 2 | 2019 | 642 | 0.600 |
Why?
|
Genetic Markers | 3 | 2016 | 2601 | 0.580 |
Why?
|
Lipoproteins, HDL | 5 | 2020 | 676 | 0.570 |
Why?
|
Comparative Effectiveness Research | 1 | 2022 | 709 | 0.560 |
Why?
|
Receptors, Interleukin-6 | 1 | 2018 | 226 | 0.560 |
Why?
|
Meta-Analysis as Topic | 3 | 2010 | 1380 | 0.550 |
Why?
|
Cluster Analysis | 7 | 2023 | 2707 | 0.500 |
Why?
|
Colitis, Ulcerative | 9 | 2020 | 1922 | 0.490 |
Why?
|
Diagnostic Tests, Routine | 3 | 2021 | 787 | 0.480 |
Why?
|
Cohort Studies | 40 | 2023 | 41487 | 0.480 |
Why?
|
Aortic Aneurysm | 2 | 2024 | 648 | 0.480 |
Why?
|
Suicide, Attempted | 6 | 2023 | 1402 | 0.460 |
Why?
|
Area Under Curve | 7 | 2021 | 1638 | 0.450 |
Why?
|
Genome-Wide Association Study | 12 | 2020 | 12690 | 0.450 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2019 | 1033 | 0.440 |
Why?
|
Apolipoprotein C-III | 3 | 2020 | 211 | 0.410 |
Why?
|
Data Collection | 2 | 2023 | 3322 | 0.410 |
Why?
|
Crohn Disease | 8 | 2019 | 2279 | 0.400 |
Why?
|
Models, Genetic | 6 | 2017 | 3442 | 0.380 |
Why?
|
Risk Factors | 42 | 2024 | 74206 | 0.370 |
Why?
|
Lung Neoplasms | 5 | 2023 | 13380 | 0.370 |
Why?
|
Sensitivity and Specificity | 20 | 2020 | 14666 | 0.370 |
Why?
|
Propensity Score | 5 | 2022 | 1913 | 0.370 |
Why?
|
Anterior Cerebral Artery | 2 | 2021 | 50 | 0.360 |
Why?
|
Calibration | 2 | 2023 | 818 | 0.360 |
Why?
|
Epitopes | 1 | 2017 | 2503 | 0.360 |
Why?
|
Laparoscopy | 1 | 2022 | 2035 | 0.350 |
Why?
|
Logistic Models | 16 | 2022 | 13255 | 0.350 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2014 | 710 | 0.340 |
Why?
|
Basilar Artery | 2 | 2021 | 205 | 0.340 |
Why?
|
Biostatistics | 7 | 2013 | 164 | 0.340 |
Why?
|
Female | 111 | 2024 | 392644 | 0.340 |
Why?
|
Middle Aged | 85 | 2024 | 220895 | 0.330 |
Why?
|
Angiography | 5 | 2014 | 1595 | 0.320 |
Why?
|
Male | 100 | 2024 | 360804 | 0.300 |
Why?
|
Multiple Sclerosis | 5 | 2021 | 3220 | 0.300 |
Why?
|
Reproducibility of Results | 18 | 2023 | 20098 | 0.300 |
Why?
|
Aged | 63 | 2024 | 169289 | 0.300 |
Why?
|
Statistics, Nonparametric | 9 | 2019 | 2850 | 0.290 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3204 | 0.290 |
Why?
|
Suicidal Ideation | 4 | 2019 | 1447 | 0.290 |
Why?
|
Lipolysis | 1 | 2009 | 212 | 0.290 |
Why?
|
Risk | 11 | 2020 | 9610 | 0.290 |
Why?
|
Life Tables | 1 | 2007 | 364 | 0.290 |
Why?
|
Unified Medical Language System | 2 | 2019 | 89 | 0.290 |
Why?
|
Forecasting | 3 | 2021 | 2928 | 0.290 |
Why?
|
Models, Theoretical | 3 | 2016 | 3575 | 0.280 |
Why?
|
Smoking | 4 | 2019 | 9053 | 0.280 |
Why?
|
Epidemiologic Studies | 2 | 2021 | 675 | 0.270 |
Why?
|
Linear Models | 7 | 2018 | 5871 | 0.270 |
Why?
|
Circle of Willis | 3 | 2021 | 78 | 0.270 |
Why?
|
Coronary Disease | 7 | 2020 | 5914 | 0.270 |
Why?
|
Multivariate Analysis | 12 | 2020 | 12059 | 0.260 |
Why?
|
Obstetric Labor Complications | 2 | 2019 | 236 | 0.260 |
Why?
|
Cardiovascular Diseases | 14 | 2018 | 15500 | 0.260 |
Why?
|
Hospitalization | 12 | 2022 | 10723 | 0.260 |
Why?
|
Epidemiologic Research Design | 1 | 2009 | 368 | 0.260 |
Why?
|
Predictive Value of Tests | 15 | 2017 | 15266 | 0.250 |
Why?
|
Receptors, Nicotinic | 1 | 2009 | 495 | 0.250 |
Why?
|
Kaplan-Meier Estimate | 5 | 2014 | 6484 | 0.250 |
Why?
|
Pulmonary Embolism | 7 | 2016 | 2567 | 0.250 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2014 | 2199 | 0.250 |
Why?
|
Coronary Artery Disease | 5 | 2019 | 6403 | 0.250 |
Why?
|
Psychopathology | 3 | 2018 | 432 | 0.250 |
Why?
|
Costs and Cost Analysis | 1 | 2011 | 1668 | 0.250 |
Why?
|
Breast Neoplasms | 9 | 2016 | 21012 | 0.240 |
Why?
|
Mental Disorders | 3 | 2020 | 6845 | 0.240 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3639 | 0.230 |
Why?
|
Cerebral Angiography | 5 | 2021 | 1281 | 0.230 |
Why?
|
Discriminant Analysis | 1 | 2004 | 222 | 0.230 |
Why?
|
Survival | 2 | 2017 | 161 | 0.230 |
Why?
|
Clinical Trials as Topic | 5 | 2021 | 8002 | 0.230 |
Why?
|
Medicare | 2 | 2021 | 6770 | 0.220 |
Why?
|
Adult | 65 | 2024 | 221177 | 0.220 |
Why?
|
Genomics | 4 | 2018 | 5821 | 0.220 |
Why?
|
Registries | 7 | 2021 | 8224 | 0.220 |
Why?
|
Biological Products | 2 | 2023 | 914 | 0.220 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1651 | 0.210 |
Why?
|
Databases, Factual | 6 | 2022 | 7967 | 0.210 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 6 | 2014 | 1222 | 0.210 |
Why?
|
Genetic Predisposition to Disease | 11 | 2023 | 17904 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2020 | 10209 | 0.200 |
Why?
|
Diabetes Mellitus | 3 | 2020 | 5840 | 0.200 |
Why?
|
Adipocytes | 1 | 2009 | 1194 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 11 | 2016 | 20570 | 0.190 |
Why?
|
Pandemics | 4 | 2022 | 8654 | 0.190 |
Why?
|
Cholesterol, HDL | 3 | 2018 | 1814 | 0.190 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2023 | 1228 | 0.190 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2009 | 1250 | 0.190 |
Why?
|
Biological Therapy | 1 | 2022 | 141 | 0.190 |
Why?
|
Dental Implants | 2 | 2006 | 795 | 0.190 |
Why?
|
Bayes Theorem | 3 | 2019 | 2330 | 0.180 |
Why?
|
Apolipoprotein A-I | 2 | 2020 | 299 | 0.180 |
Why?
|
Markov Chains | 2 | 2022 | 966 | 0.180 |
Why?
|
Genotype | 9 | 2023 | 12990 | 0.180 |
Why?
|
Pregnancy Complications | 3 | 2019 | 2947 | 0.180 |
Why?
|
Least-Squares Analysis | 1 | 2021 | 369 | 0.180 |
Why?
|
Middle Cerebral Artery | 1 | 2021 | 275 | 0.180 |
Why?
|
Iopamidol | 3 | 2009 | 186 | 0.170 |
Why?
|
Time Factors | 14 | 2019 | 39967 | 0.170 |
Why?
|
Classification | 2 | 2017 | 127 | 0.170 |
Why?
|
Disease Progression | 8 | 2021 | 13506 | 0.170 |
Why?
|
Chondrocalcinosis | 1 | 2021 | 84 | 0.170 |
Why?
|
AIDS Vaccines | 1 | 2006 | 896 | 0.160 |
Why?
|
Spondylarthritis | 1 | 2020 | 61 | 0.160 |
Why?
|
Apolipoproteins E | 3 | 2020 | 1444 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2022 | 4352 | 0.160 |
Why?
|
Artificial Intelligence | 1 | 2013 | 2578 | 0.160 |
Why?
|
Military Personnel | 3 | 2017 | 1246 | 0.160 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2002 | 563 | 0.160 |
Why?
|
Stochastic Processes | 1 | 2020 | 355 | 0.160 |
Why?
|
Spondylitis, Ankylosing | 1 | 2020 | 155 | 0.160 |
Why?
|
Colectomy | 2 | 2022 | 688 | 0.160 |
Why?
|
Prevalence | 9 | 2021 | 15732 | 0.160 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 857 | 0.150 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4527 | 0.150 |
Why?
|
Gastrointestinal Agents | 3 | 2022 | 510 | 0.150 |
Why?
|
Current Procedural Terminology | 1 | 2018 | 89 | 0.150 |
Why?
|
Software | 5 | 2017 | 4434 | 0.150 |
Why?
|
Treatment Outcome | 13 | 2023 | 64680 | 0.150 |
Why?
|
C-Reactive Protein | 4 | 2014 | 3826 | 0.150 |
Why?
|
Retrospective Studies | 30 | 2024 | 80636 | 0.150 |
Why?
|
Mortality | 1 | 2009 | 2901 | 0.150 |
Why?
|
Nonlinear Dynamics | 2 | 2018 | 492 | 0.150 |
Why?
|
Peer Review, Research | 1 | 2021 | 340 | 0.150 |
Why?
|
Apolipoproteins | 1 | 2019 | 326 | 0.140 |
Why?
|
Receptors, Formyl Peptide | 1 | 2018 | 146 | 0.140 |
Why?
|
Sampling Studies | 2 | 2015 | 615 | 0.140 |
Why?
|
Automation | 1 | 2019 | 586 | 0.140 |
Why?
|
Heroin Dependence | 1 | 2017 | 172 | 0.140 |
Why?
|
Veterans | 2 | 2022 | 2647 | 0.140 |
Why?
|
Contrast Media | 8 | 2012 | 5311 | 0.140 |
Why?
|
International Normalized Ratio | 1 | 2018 | 382 | 0.140 |
Why?
|
Patient Selection | 2 | 2021 | 4244 | 0.130 |
Why?
|
Causality | 3 | 2020 | 1242 | 0.130 |
Why?
|
Dementia | 3 | 2020 | 2686 | 0.130 |
Why?
|
Vitamin D | 3 | 2015 | 3303 | 0.130 |
Why?
|
Hypertension, Pulmonary | 2 | 2017 | 1578 | 0.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 556 | 0.130 |
Why?
|
GRB10 Adaptor Protein | 1 | 2015 | 23 | 0.130 |
Why?
|
United States | 18 | 2022 | 72334 | 0.130 |
Why?
|
Apolipoproteins C | 1 | 2015 | 59 | 0.130 |
Why?
|
HIV Infections | 6 | 2017 | 17351 | 0.130 |
Why?
|
Comorbidity | 6 | 2022 | 10508 | 0.130 |
Why?
|
Colorectal Neoplasms | 4 | 2017 | 6935 | 0.130 |
Why?
|
Young Adult | 19 | 2023 | 59243 | 0.130 |
Why?
|
Therapeutics | 1 | 2015 | 113 | 0.130 |
Why?
|
Aneurysm | 1 | 2018 | 337 | 0.120 |
Why?
|
Aged, 80 and over | 16 | 2024 | 58976 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 888 | 0.120 |
Why?
|
Magnesium | 1 | 2018 | 804 | 0.120 |
Why?
|
Confidentiality | 1 | 2019 | 609 | 0.120 |
Why?
|
Lipopolysaccharides | 1 | 2002 | 2206 | 0.120 |
Why?
|
Models, Biological | 6 | 2018 | 9469 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 3 | 2022 | 2571 | 0.110 |
Why?
|
Prospective Studies | 11 | 2022 | 54425 | 0.110 |
Why?
|
Suicide | 2 | 2015 | 1601 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 934 | 0.110 |
Why?
|
Vitamin D Deficiency | 2 | 2013 | 1388 | 0.110 |
Why?
|
Textile Industry | 1 | 2013 | 74 | 0.110 |
Why?
|
Publishing | 1 | 2021 | 833 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2019 | 12148 | 0.110 |
Why?
|
Hypolipidemic Agents | 1 | 2018 | 609 | 0.110 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2023 | 1428 | 0.110 |
Why?
|
Genetic Research | 1 | 2014 | 171 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1372 | 0.110 |
Why?
|
Heart Failure | 4 | 2022 | 11669 | 0.110 |
Why?
|
Medical Audit | 1 | 2014 | 453 | 0.110 |
Why?
|
Hypoglycemic Agents | 3 | 2017 | 3085 | 0.110 |
Why?
|
Blood Sedimentation | 1 | 2014 | 235 | 0.110 |
Why?
|
Electrocardiography | 4 | 2009 | 6377 | 0.100 |
Why?
|
Haplotypes | 1 | 2018 | 2713 | 0.100 |
Why?
|
Anthropometry | 1 | 2017 | 1349 | 0.100 |
Why?
|
Survival Rate | 5 | 2014 | 12725 | 0.100 |
Why?
|
Drug Therapy | 1 | 2015 | 503 | 0.100 |
Why?
|
Arousal | 1 | 2018 | 1166 | 0.100 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 177 | 0.100 |
Why?
|
Adolescent | 15 | 2023 | 88319 | 0.100 |
Why?
|
Lung Diseases | 2 | 2013 | 1909 | 0.100 |
Why?
|
Magnetic Resonance Angiography | 2 | 2010 | 1432 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2016 | 868 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1175 | 0.100 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2720 | 0.100 |
Why?
|
Antibodies, Antinuclear | 1 | 2013 | 343 | 0.090 |
Why?
|
Genetic Variation | 3 | 2017 | 6567 | 0.090 |
Why?
|
Endotoxins | 1 | 2013 | 520 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 5 | 2021 | 4063 | 0.090 |
Why?
|
Biomedical Research | 2 | 2021 | 3429 | 0.090 |
Why?
|
Air Pollutants, Occupational | 1 | 2013 | 407 | 0.090 |
Why?
|
Sjogren's Syndrome | 1 | 2013 | 237 | 0.090 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2012 | 214 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1666 | 0.090 |
Why?
|
Pregnant Women | 1 | 2015 | 566 | 0.090 |
Why?
|
Statistical Distributions | 1 | 2010 | 63 | 0.090 |
Why?
|
Sequence Analysis | 1 | 2011 | 240 | 0.090 |
Why?
|
Anticoagulants | 2 | 2018 | 4812 | 0.090 |
Why?
|
Parturition | 1 | 2014 | 445 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1793 | 0.090 |
Why?
|
Pregnancy Outcome | 2 | 2019 | 2921 | 0.090 |
Why?
|
Hyperlipidemias | 1 | 2015 | 771 | 0.090 |
Why?
|
Thiazolidinediones | 2 | 2010 | 461 | 0.090 |
Why?
|
Longitudinal Studies | 5 | 2021 | 14605 | 0.090 |
Why?
|
Deoxyguanosine | 1 | 2010 | 93 | 0.090 |
Why?
|
Epigenomics | 1 | 2016 | 943 | 0.090 |
Why?
|
Reference Values | 2 | 2007 | 4920 | 0.090 |
Why?
|
Depressive Disorder | 2 | 2013 | 3728 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1483 | 0.090 |
Why?
|
Endovascular Procedures | 1 | 2023 | 2183 | 0.080 |
Why?
|
Boston | 6 | 2021 | 9326 | 0.080 |
Why?
|
Fractures, Bone | 1 | 2021 | 2046 | 0.080 |
Why?
|
Self-Injurious Behavior | 1 | 2015 | 566 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 2 | 2021 | 335 | 0.080 |
Why?
|
Bipolar Disorder | 2 | 2018 | 5092 | 0.080 |
Why?
|
Poisson Distribution | 1 | 2010 | 504 | 0.080 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2009 | 87 | 0.080 |
Why?
|
Severity of Illness Index | 6 | 2021 | 15842 | 0.080 |
Why?
|
Cinnamates | 1 | 2009 | 59 | 0.080 |
Why?
|
Lipoproteins | 1 | 2013 | 881 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1866 | 0.080 |
Why?
|
Radioligand Assay | 1 | 2009 | 366 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1897 | 0.080 |
Why?
|
Coronary Angiography | 3 | 2009 | 4471 | 0.080 |
Why?
|
Endpoint Determination | 1 | 2011 | 590 | 0.080 |
Why?
|
Birth Weight | 1 | 2016 | 2103 | 0.080 |
Why?
|
Autistic Disorder | 1 | 2017 | 1220 | 0.070 |
Why?
|
Iodine | 1 | 2010 | 288 | 0.070 |
Why?
|
Drug Combinations | 1 | 2014 | 2048 | 0.070 |
Why?
|
Hypothyroidism | 1 | 2013 | 668 | 0.070 |
Why?
|
Heart Ventricles | 2 | 2012 | 3807 | 0.070 |
Why?
|
Thrombosis | 1 | 2022 | 2942 | 0.070 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2008 | 146 | 0.070 |
Why?
|
Computational Biology | 1 | 2020 | 3518 | 0.070 |
Why?
|
Patient Positioning | 1 | 2010 | 326 | 0.070 |
Why?
|
Carrier Proteins | 2 | 2018 | 4936 | 0.070 |
Why?
|
Iodine Compounds | 1 | 2007 | 28 | 0.070 |
Why?
|
Arthritis, Psoriatic | 1 | 2010 | 219 | 0.070 |
Why?
|
Thromboembolism | 1 | 2014 | 995 | 0.070 |
Why?
|
Delivery, Obstetric | 1 | 2014 | 940 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 488 | 0.070 |
Why?
|
Cognition | 3 | 2020 | 6990 | 0.070 |
Why?
|
Neoplasms | 5 | 2018 | 22170 | 0.070 |
Why?
|
Graft Occlusion, Vascular | 1 | 2010 | 537 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3133 | 0.070 |
Why?
|
HIV-1 | 2 | 2017 | 6863 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2011 | 803 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4740 | 0.070 |
Why?
|
Erythropoietin | 1 | 2011 | 719 | 0.070 |
Why?
|
Washington | 1 | 2007 | 315 | 0.070 |
Why?
|
Follow-Up Studies | 9 | 2020 | 39106 | 0.070 |
Why?
|
Cystic Fibrosis | 2 | 2007 | 1285 | 0.070 |
Why?
|
Colonoscopy | 1 | 2014 | 1394 | 0.070 |
Why?
|
Denmark | 2 | 2019 | 771 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2155 | 0.070 |
Why?
|
Medical Informatics | 1 | 2013 | 733 | 0.070 |
Why?
|
Odds Ratio | 4 | 2019 | 9646 | 0.060 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 370 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2017 | 3466 | 0.060 |
Why?
|
Veins | 1 | 2010 | 768 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2013 | 868 | 0.060 |
Why?
|
Peptides | 1 | 2018 | 4358 | 0.060 |
Why?
|
Radiographic Image Enhancement | 1 | 2010 | 876 | 0.060 |
Why?
|
Cesarean Section | 1 | 2014 | 1396 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2056 | 0.060 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2016 | 1413 | 0.060 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2016 | 1393 | 0.060 |
Why?
|
Dental Implantation, Endosseous | 2 | 2006 | 531 | 0.060 |
Why?
|
Life Style | 1 | 2017 | 3917 | 0.060 |
Why?
|
Plant Extracts | 1 | 2009 | 498 | 0.060 |
Why?
|
Incidence | 7 | 2022 | 21353 | 0.060 |
Why?
|
Clostridium Infections | 1 | 2012 | 558 | 0.060 |
Why?
|
Proteomics | 1 | 2018 | 3849 | 0.060 |
Why?
|
Calcium | 1 | 2018 | 5722 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 6310 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3801 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2498 | 0.060 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 6132 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2927 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 11903 | 0.060 |
Why?
|
Artifacts | 2 | 2010 | 1911 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3245 | 0.060 |
Why?
|
CA-19-9 Antigen | 1 | 2004 | 106 | 0.060 |
Why?
|
Dental Research | 1 | 2005 | 61 | 0.060 |
Why?
|
Molecular Structure | 1 | 2009 | 1880 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4028 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2011 | 1742 | 0.060 |
Why?
|
Pulmonary Artery | 2 | 2010 | 1927 | 0.060 |
Why?
|
Dental Restoration Failure | 1 | 2005 | 155 | 0.060 |
Why?
|
Reference Standards | 1 | 2007 | 1003 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9280 | 0.060 |
Why?
|
Glioblastoma | 2 | 2016 | 3482 | 0.060 |
Why?
|
Recurrence | 3 | 2021 | 8465 | 0.060 |
Why?
|
Age Factors | 3 | 2021 | 18395 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2019 | 3223 | 0.060 |
Why?
|
Respiration | 1 | 2010 | 1657 | 0.060 |
Why?
|
Population Surveillance | 1 | 2014 | 2598 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2491 | 0.050 |
Why?
|
Child | 10 | 2022 | 80153 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7879 | 0.050 |
Why?
|
Occupational Exposure | 1 | 2013 | 1813 | 0.050 |
Why?
|
Endoleak | 1 | 2023 | 111 | 0.050 |
Why?
|
Pattern Recognition, Automated | 1 | 2009 | 997 | 0.050 |
Why?
|
Kidney Failure, Chronic | 2 | 2016 | 2471 | 0.050 |
Why?
|
Orphan Nuclear Receptors | 1 | 2003 | 63 | 0.050 |
Why?
|
Sequence Homology | 1 | 2003 | 196 | 0.050 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 1 | 2002 | 28 | 0.050 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2008 | 628 | 0.050 |
Why?
|
Angiopoietins | 1 | 2003 | 85 | 0.050 |
Why?
|
Lipids | 1 | 2013 | 3341 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3688 | 0.050 |
Why?
|
CA-125 Antigen | 1 | 2004 | 281 | 0.050 |
Why?
|
RNA, Viral | 1 | 2010 | 2846 | 0.050 |
Why?
|
Lower Extremity | 1 | 2010 | 1202 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2244 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2007 | 1440 | 0.050 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 26125 | 0.050 |
Why?
|
Medical Records | 1 | 2007 | 1408 | 0.050 |
Why?
|
Pregnancy | 6 | 2019 | 29874 | 0.050 |
Why?
|
Renal Dialysis | 1 | 2011 | 1797 | 0.050 |
Why?
|
Vascular Surgical Procedures | 1 | 2010 | 1489 | 0.050 |
Why?
|
Massachusetts | 4 | 2018 | 8830 | 0.050 |
Why?
|
Obesity | 2 | 2023 | 12947 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2003 | 5789 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2010 | 1784 | 0.050 |
Why?
|
Prostatic Neoplasms | 4 | 2011 | 11118 | 0.050 |
Why?
|
Creatinine | 2 | 2019 | 1899 | 0.040 |
Why?
|
Body Height | 1 | 2007 | 1570 | 0.040 |
Why?
|
Liver Cirrhosis, Biliary | 2 | 2012 | 108 | 0.040 |
Why?
|
Privacy | 1 | 2022 | 233 | 0.040 |
Why?
|
British Columbia | 1 | 2020 | 241 | 0.040 |
Why?
|
Hemophilia A | 1 | 2003 | 360 | 0.040 |
Why?
|
Neuropsychological Tests | 3 | 2020 | 7045 | 0.040 |
Why?
|
Research | 2 | 2023 | 1982 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2011 | 2469 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2004 | 1814 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 687 | 0.040 |
Why?
|
Psychiatry | 1 | 2011 | 1693 | 0.040 |
Why?
|
Child, Preschool | 5 | 2021 | 42230 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1435 | 0.040 |
Why?
|
Alleles | 2 | 2023 | 6863 | 0.040 |
Why?
|
Colestipol | 1 | 2018 | 11 | 0.040 |
Why?
|
Epilepsy | 1 | 2014 | 3290 | 0.040 |
Why?
|
Cholestyramine Resin | 1 | 2018 | 25 | 0.040 |
Why?
|
Blood Vessel Prosthesis | 1 | 2023 | 952 | 0.040 |
Why?
|
Observer Variation | 3 | 2010 | 2606 | 0.040 |
Why?
|
Vital Signs | 1 | 2019 | 144 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2009 | 3096 | 0.040 |
Why?
|
Fibric Acids | 1 | 2018 | 27 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2016 | 4575 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2018 | 7827 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5492 | 0.040 |
Why?
|
Triglycerides | 2 | 2020 | 2461 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 3810 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 362 | 0.040 |
Why?
|
Public Health | 1 | 2011 | 2669 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1328 | 0.040 |
Why?
|
Stroke Volume | 2 | 2022 | 5496 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2008 | 2118 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 1246 | 0.040 |
Why?
|
Protein Stability | 1 | 2018 | 578 | 0.030 |
Why?
|
Analysis of Variance | 3 | 2012 | 6228 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2017 | 266 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 598 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2021 | 26198 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2010 | 3979 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2014 | 4761 | 0.030 |
Why?
|
Independent Living | 1 | 2020 | 579 | 0.030 |
Why?
|
Hemostasis | 1 | 2018 | 467 | 0.030 |
Why?
|
Depression | 1 | 2015 | 8124 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2021 | 5247 | 0.030 |
Why?
|
Monte Carlo Method | 2 | 2012 | 1258 | 0.030 |
Why?
|
Waist Circumference | 1 | 2019 | 935 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2254 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1702 | 0.030 |
Why?
|
Ligands | 1 | 2002 | 3272 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2016 | 350 | 0.030 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2016 | 276 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2016 | 386 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2018 | 582 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2016 | 302 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 4021 | 0.030 |
Why?
|
Genetic Loci | 2 | 2016 | 2632 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2016 | 15631 | 0.030 |
Why?
|
Cotton Fiber | 1 | 2013 | 25 | 0.030 |
Why?
|
Rectal Fistula | 1 | 2014 | 75 | 0.030 |
Why?
|
Americas | 1 | 2014 | 111 | 0.030 |
Why?
|
Gene Frequency | 2 | 2011 | 3606 | 0.030 |
Why?
|
Botswana | 1 | 2017 | 1048 | 0.030 |
Why?
|
Cholesterol | 1 | 2003 | 2904 | 0.030 |
Why?
|
Mice | 3 | 2009 | 81525 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2021 | 9000 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8547 | 0.030 |
Why?
|
Insurance Claim Reporting | 1 | 2014 | 166 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2009 | 14414 | 0.030 |
Why?
|
Genetic Linkage | 1 | 1999 | 2341 | 0.030 |
Why?
|
New Zealand | 1 | 2014 | 358 | 0.030 |
Why?
|
Piperidines | 1 | 2022 | 1656 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2009 | 18965 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.030 |
Why?
|
Thyroiditis | 1 | 2013 | 86 | 0.030 |
Why?
|
Penicillamine | 1 | 2012 | 60 | 0.030 |
Why?
|
Asia | 1 | 2014 | 619 | 0.020 |
Why?
|
Fibrosis | 1 | 2019 | 2049 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2018 | 1192 | 0.020 |
Why?
|
Transglutaminases | 1 | 2013 | 197 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9420 | 0.020 |
Why?
|
Base Sequence | 1 | 2003 | 12441 | 0.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 397 | 0.020 |
Why?
|
Iodide Peroxidase | 1 | 2013 | 294 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 376 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 506 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5315 | 0.020 |
Why?
|
Inflammation | 2 | 2022 | 10773 | 0.020 |
Why?
|
Dust | 1 | 2013 | 487 | 0.020 |
Why?
|
Nigeria | 1 | 2014 | 770 | 0.020 |
Why?
|
Antioxidants | 1 | 2018 | 1668 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2371 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1902 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 563 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 17635 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1241 | 0.020 |
Why?
|
Sex Factors | 2 | 2015 | 10552 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1648 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2880 | 0.020 |
Why?
|
Postoperative Care | 1 | 2016 | 1468 | 0.020 |
Why?
|
Phylogeny | 1 | 2017 | 2811 | 0.020 |
Why?
|
Adiposity | 1 | 2019 | 1878 | 0.020 |
Why?
|
Pyrimidines | 1 | 2022 | 3028 | 0.020 |
Why?
|
Hospital Information Systems | 1 | 2012 | 394 | 0.020 |
Why?
|
Iohexol | 1 | 2010 | 204 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2010 | 11460 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2915 | 0.020 |
Why?
|
Radiation Dosage | 2 | 2008 | 1958 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2011 | 352 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2014 | 572 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36192 | 0.020 |
Why?
|
Puerto Rico | 1 | 2010 | 376 | 0.020 |
Why?
|
Hepatitis C | 1 | 2019 | 1584 | 0.020 |
Why?
|
Serum Albumin | 1 | 2012 | 672 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4174 | 0.020 |
Why?
|
Needs Assessment | 1 | 2015 | 1139 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2008 | 119 | 0.020 |
Why?
|
Aftercare | 1 | 2015 | 914 | 0.020 |
Why?
|
Animals | 3 | 2009 | 168459 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 2382 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 951 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2281 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3416 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3250 | 0.020 |
Why?
|
New England | 1 | 2011 | 1054 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3882 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3600 | 0.020 |
Why?
|
Viral Load | 1 | 2017 | 3332 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2018 | 6019 | 0.020 |
Why?
|
China | 1 | 2013 | 2369 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 874 | 0.020 |
Why?
|
Body Mass Index | 2 | 2019 | 12953 | 0.020 |
Why?
|
Taiwan | 1 | 2008 | 521 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3530 | 0.020 |
Why?
|
Liver | 1 | 2003 | 7529 | 0.020 |
Why?
|
Europe | 1 | 2014 | 3422 | 0.020 |
Why?
|
Resilience, Psychological | 1 | 2015 | 788 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2019 | 3060 | 0.020 |
Why?
|
Vascular Patency | 1 | 2010 | 911 | 0.020 |
Why?
|
Family | 1 | 2017 | 3194 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9351 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1809 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 1998 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10766 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2007 | 882 | 0.020 |
Why?
|
Hemoglobins | 1 | 2012 | 1525 | 0.020 |
Why?
|
Genetic Testing | 1 | 1999 | 3537 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12341 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9606 | 0.020 |
Why?
|
Tyrosine | 1 | 2009 | 1440 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2014 | 1589 | 0.020 |
Why?
|
DNA | 1 | 2017 | 7212 | 0.010 |
Why?
|
Dental Prosthesis Design | 1 | 2005 | 264 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11121 | 0.010 |
Why?
|
Benchmarking | 1 | 2008 | 1045 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2010 | 1496 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3443 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2009 | 2425 | 0.010 |
Why?
|
Exercise | 1 | 2017 | 5890 | 0.010 |
Why?
|
Patient Readmission | 1 | 2014 | 3270 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2011 | 2775 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2008 | 1376 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2010 | 3113 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3712 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8320 | 0.010 |
Why?
|
Lod Score | 1 | 1999 | 600 | 0.010 |
Why?
|
Acute Disease | 1 | 2008 | 7237 | 0.010 |
Why?
|
Heart Rate | 1 | 2008 | 4195 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 6965 | 0.010 |
Why?
|
Pilot Projects | 1 | 2008 | 8631 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2008 | 2895 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36426 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9177 | 0.010 |
Why?
|
Gene Expression | 1 | 2006 | 7581 | 0.010 |
Why?
|
Blood Pressure | 1 | 2008 | 8481 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 16981 | 0.010 |
Why?
|
Mass Screening | 1 | 2007 | 5428 | 0.010 |
Why?
|
Genome | 1 | 1999 | 1740 | 0.010 |
Why?
|
Signal Transduction | 1 | 2009 | 23445 | 0.000 |
Why?
|